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Since cytochromes P450 are external monooxygenases, available surrogate
redox partners have been used to reconstitute the P450 activity. However, the
effect of various ratios of P450s and the redox proteins have not been exten-
sively studied so far, although different combinations of the redox partners
have shown variations in substrate conversion. To address this issue,
CYP260A1 was reconstituted with various ratios of adrenodoxin and adreno-
doxin reductase to convert 11-deoxycorticosterone, and the products were
characterized by NMR. We show the effect of the available redox protein
ratios not only on the P450 catalytic activity but also on the product pattern.
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Cytochromes P450 (P450s), the heme-containing
monoxygenase enzymes, are able to catalyze a variety
of chemical reactions including C-H functionalization,
aromatic hydroxylation, dealkylation, C–C lyase activ-
ity, decarboxylation, nitration and carbene transfer
[1,2]. P450s are also involved in the biosynthesis of
natural products [3]. They require electrons for their
activity, which can be donated by autologous or
heterologous redox partners via an electron transfer
chain [4]. However, the requirement of efficient redox
partners to deliver electrons from NADH or NADPH
to a P450 is the bottleneck for its application [5].
The identification of functional autologous or
heterologous redox partners for orphan microbial
P450s is complicated, because the P450s and potential
redox partners are not always found in the same gene
cluster [6]. However, surrogate redox partners are
often employed to reconstitute catalytic activities for
such novel P450s. Several different redox systems, like
putidaredoxin reductase (PdR) – putidaredoxin (Pdx)
from Pseudomonas putida, adrenodoxin reductase
homolog 1 (Arh) – endogenous ferredoxin component
(etp1) from Schizosaccharomyces pombe [7], ferredoxin
reductase (FdR) – ferredoxin (Fdx) from Escherichia
coli [8], ferredoxin reductase (FdR) – flavodoxin
(ykuN/ykuP) from Bacillus subtilis [9], adrenodoxin
reductase (AdR) – adrenodoxin (Adx) from bovine
adrenals [10], the reductase domain of CYP102A1
(BMR) [9,11], the FMN- and Fe/S-containing domain
of p450RhF from Rhodococcus sp. [12], a phthalate
family oxygenase reductase (PFOR) from Pseudomonas
putida KT24440 [13], along with the chimeric systems
Abbreviations
AdR, adrenodoxin reductase; Adx, adrenodoxin; DOC, deoxycorticosterone.
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of SynFdx (Fd) from Synechocystis and the ferredoxin
NADP+ reductase (FNR) from Chlamydomonas rein-
hardtii [14] and Adx-FpR from E. coli [15] as well as
the commercially available spinach ferredoxin (Fdx)
and ferredoxin reductase (FdR) [16,17] have been used
in different ratios to reconstitute the activity of various
P450s. However, the ratios of P450 and the redox
partners used for the substrate conversions were not
consistent in the different studies. In some studies,
more than a 10-fold [9,18–20], a 20-fold [21,22], a 50–
80 fold [23–25] or even more than a 200-fold [26,27]
higher ratio of Fdx compared with the P450 was
employed for the in vitro conversion of the related
substrate. In all these studies, the main aim of employ-
ing the various ratios was to make the P450 func-
tional, but the effect of different ratios of the redox
partners was not studied. Nevertheless, it has been
shown that the use of surrogate redox systems for a
novel P450 not only showed variations in the substrate
conversion [9,14,15,28,29] but also displayed different
product selectivities [30]. In addition, the use of non-
physiological substrates containing multiple oxidation
sites to be attacked by a P450, generally resulted in
different oxidized products depending on the reaction
conditions and incubation time, in which the earlier
product(s) might serve as a substrate for further con-
versions [31,32]. Such multistep or sequential oxida-
tions of a substrate by a P450 results in either a
distributive, (obtaining multihydroxylated products at
once as shown, e.g. for CYP19 [33,34]) or a processive
(step-wise sequential reactions as observed for the con-
version of nitrosamines to aldehydes and then car-
boxylic acids by CYP2A6 [32,35]) product distribution.
While using a nonphysiological substrate for a P450
or a mutated variant of a specific P450, in some of the
cases, the product patterns that are observed in an
in vitro reaction do not replicate in the in vivo conver-
sion [36]. In general, the amounts of the redox partners
being present during the coexpression of P450 and
redox partners in a whole-cell system are not compara-
ble to the amounts of the redox proteins in the in vitro
reaction. Therefore, this study attempted to investigate
this issue in more detail. In order to understand the
effect of the redox protein ratio of Adx and AdR on
the P450-dependent reaction, different amounts of the
redox proteins were used for the conversion of 11-deox-
ycorticosterone (DOC) by CYP260A1. We studied the
consequences on the conversion of DOC and its pro-
duct selectivity during the in vitro reaction and the
E. coli-based whole-cell system. The obtained main
products were purified and characterized by liquid
chromatography–mass spectrometry (LC–MS) and 1D
and 2D NMR analysis.
Materials and methods
Molecular cloning, expression and purification of
CYP260A1
The heterologous expression, purification and characteriza-
tion of CYP260A1 were performed as described elsewhere
[10]. The mammalian adrenodoxin reductase, AdR, and
truncated adrenodoxin, Adx4–108, were expressed and puri-
fied as described [37,38].
In vitro enzyme activity assay
The conversion of DOC by CYP260A1 was carried out with
the heterologous electron partners. The in vitro reconstitu-
tion assay to determine the steady-state conversion of DOC
(100 lM) was performed in a final volume of 250 lL con-
taining a mixture of CYP260A1 (0.5 lM), Adx (5 lM), AdR
(1.5 lM) (CYP260A1 : Adx : AdR of 1 : 10 : 3) and sub-
strate (100 lM) in 20 mM potassium phosphate buffer (pH
7.4). The reaction was started by adding NADPH (500 lM)
and incubating for 20 min at 30 °C, and stopped by the
addition of chloroform (500 lL). The sample was mixed
vigorously, and the organic phase was extracted twice with
chloroform. The pooled samples were dried and analyzed
by HPLC as described [10]. The time-dependent conversion
was done by increasing the incubation time (5–100 min).
The NADPH-dependent conversion of the substrate was
done using 100 lM to 4 mM freshly prepared NADPH
under the same condition as explained. The reaction was
done in the absence or presence of a NADPH regeneration
system when needed. The NADPH-regenerating system con-
sists of glucose 6-phosphate (5 mM), glucose 6-phosphate
dehydrogenase (1 U) and MgCl2 (1 mM). Protein ratios of
CYP260A1 : Adx : AdR of (1 : 1 : 1, 1 : 2 : 0.5, 1 : 1 : 5,
3 : 2.5 : 1, 8 : 3 : 1, 1 : 5 : 1, 1 : 5 : 3, 1 : 5 : 5, 1 : 10 : 1,
1 : 10 : 2, 1 : 10 : 3, 1 : 10 : 5, 1 : 10 : 7, 1 : 10 : 10,
1 : 20 : 1, 1 : 20 : 3, 1 : 20 : 5, 1 : 20 : 7, 1 : 20 : 10,
1 : 10 : 15 or 1 : 20 : 20) were used. The related protein
concentrations are used as mentioned in Table 1 and Fig. 2.
To investigate the effect of radical scavengers on the cat-
alytic rate, the in vitro conversions were performed with the
addition of ascorbate (20 mM), catalase (20 U) and super-
oxide-dismutase (SOD) (3 U), individually as well as in
combination. To determine whether hydrogen peroxide
(H2O2) could be applied to reconstitute the activity of
CYP260A1, H2O2 was used in a final concentration of
50 lM. The reactions were stopped, extracted and analyzed
as described below. All the experiments were performed
using the same batch of purified proteins.
Whole-cell biotransformation using resting cells
The whole-cell biotransformation assay was performed in
E. coli C43(DE3) cells. The cells were transformed with two
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plasmids, one for the CYP260A1 and the other one for the
redox partners AdR and Adx4–108 as described [15]. The
conversion of DOC by the resting cells expressing the redox
partners and CYP260A1 was performed as described [10].
Detection and analysis of substrate conversion
by CYP260A1
The analysis of the DOC conversion in HPLC and LC–MS
was performed as described [10]. Briefly, the in vitro and the
in vivo conversions of the steroids were analyzed by reversed
phase HPLC. After evaporation of the organic (chloroform)
phase, the steroids were resuspended in 80% acetonitrile
and separated on a Jasco reversed phase HPLC system
(Tokyo, Japan) composed of an auto sampler AS-2050 plus,
a pump PU-2080, a gradient mixer LG-2080-02 and an UV-
detector UV-2075. A reversed phase column (Nucleodur
R100-5 C18ec, particle size 3 lm, length 125 mm, internal
diameter 4 mm, Macherey–Nagel) was used to separate the
substrate (DOC) from its products (1a-,14a-dihydroxy-11-
DOC, 1a-hydroxy-11-DOC or C1-C2-ene-11-DOC). The
separation of the steroids was done by a gradient elution of
acetonitrile 10–100% for 0–10 min and was monitored at
240 nm. The column temperature was kept constant at
40 °C with a peltier oven. A quantity of 20 lL of the sam-
ples was injected for analysis. The peaks were identified
using CHROMPASS software (V.1.7.403.1, Jasco, Gross-
Umstadt, Germany) and the conversion rate (nmol total
product per nmol CYP260A1 per min) was calculated.
DOC, 1a-hydroxyl-11-DOC and C1-C2-ene-11-DOC
(NMR-characterized) were used as standards to identify the
retention time (RT) of the peaks on HPLC.
Binding study of DOC and 1a-hydroxy-11-DOC
Spin-state shifts upon substrate binding were assayed at
25 °C under aerobic conditions using an UV–visible scan-
ning spectrophotometer (UV-2101PC, Shimadzu, Japan)
equipped with two tandem quartz cuvettes (Hellma, M€ull-
heim, Germany) as described [10,29]. One chamber of each
cuvette contained 1.12 lM CYP260A1 in 800 lL of 10 mM
potassium phosphate buffer, pH 7.4, whereas the second
chamber contained buffer alone. The titration of the sub-
strates (DOC and 1a-hydroxyl-11-DOC dissolved in DMSO)
was done by adding small (<1 lL) aliquots of an appropriate
stock of the substrate into the P450 containing chamber of
the sample cuvette. An equal amount of the substrate was
also added into the buffer containing chamber of the refer-
ence cuvette, and spectral changes between 200 and 700 nm
were recorded. The overlaid difference spectra from 350 to
500 nm produced by subtraction of the spectrum for ligand-
free CYP260A1 from the successive spectra for
substrate-bound species accumulated during the titration of
testosterone and androstenedione were obtained.
The dissociation constants (Kd) for CYP260A1 with
DOC and 1a-hydroxylated DOC were calculated by fitting
the peak-to-trough difference against substrate concentra-
tion to a nonlinear tight binding quadratic equation [39].
The relevant equation is: DA = (Amax/2[E]) {(Kd + [E] + [S])
 {(Kd + [E] + [S])2  4 [E] [S]}1/2}, where DA represents
the observed peak-to-trough absorbance difference at each
substrate addition, Amax is the maximum absorbance differ-
ence at substrate saturation, [E] is the total enzyme
(CYP260A1) concentration and [S] is the substrate concen-
tration. The data fitting was performed using ORIGIN 8.1G
software (OriginPro 9.1; OriginLab Corporation, North-
ampton, MA, USA). All titrations were done for three
times and the Kd values reported are the mean for the three
sets of the experimental data.
NMR characterization of the CYP260A1 product
The fractions of the purified product were pooled and dried
in a rotary evaporator. The residue was dissolved in CDCl3
for NMR analysis. NMR (1H and 13C NMR) data were
recorded with a Bruker DRX (Rheinstetten, Germany) 500
NMR spectrometer at 300 K at the NMR spectroscopy
facility (Institut f€ur Pharmazeutische Biologie, Universit€at
des Saarlandes). The chemical shifts were relative to CHCl3
at d 7.24 (1H NMR) or CDCl3 at d 77.00 (
13C NMR) using
the standard d notation in parts per million (p.p.m.). The
1D NMR (1H and 13C NMR, DEPT135) and the 2D
NMR spectra (gs-HH-COSY, gs-NOESY, gs-HSQCED,
and gs-HMBC) was recorded using the Bruker pulse pro-
gram library.
Table 1. Rate of conversion of DOC by CYP260A1 using different
redox protein ratios of Adx and AdR.
CYP260A1 : Adx : AdR
Rate (min1) Remarks
Protein
concentration [lM] Ratio
nmol total products
per nmol
CYP260A1 per min
Figure 2,
entry
0.5 : 2.5 : 0.5 1 : 5 : 1 1.10 F
0.5 : 2.5 : 1.5 1 : 5 : 3 1.62 G
0.5 : 2.5 : 2.5 1 : 5 : 5 0.30  0.06 H
0.5 : 5 : 0.5 1 : 10 : 1 1.50  0.12 I
0.5 : 5 : 1.0 1 : 10 : 2 1.55  0.02 J
0.5 : 5 : 1.5 1 : 10 : 3 1.96  0.10 K
0.5 : 5 : 2.5 1 : 10: 5 0.70 L
0.5 : 5 : 3.5 1 : 10 : 7 0.40  0.04 M
0.5 : 5 : 5.0 1 : 10 : 10 0.27 N
0.5 : 10 : 0.5 1 : 20 : 1 2.36  0.07 O
0.5 : 10 : 1.5 1 : 20 : 3 2.61  0.10 P
0.5 : 10 : 2.5 1 : 20 : 5 2.44  0.01 Q
0.5 : 10 : 3.5 1 : 20 : 7 2.02 R
0.5 : 10 : 5.0 1 : 20 : 10 2.18 S
0.5 : 10 : 7.5 1 : 20 : 15 1.90 T
0.5 : 10 : 10.0 1 : 20 : 20 0.54 U
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Results and Discussion
Determination of in vitro steady-state conditions
for DOC conversion by CYP260A1
In order to investigate the effect of redox protein
ratios for the conversion of DOC by CYP260A1, we
employed the bovine redox partners Adx(4–108) and
AdR, which have been identified as the most efficient
redox partners for several myxobacterial [15,29,40] and
Bacillus [9,41] P450s, as well as the CYP260 family
from Sorangium cellulosum So ce56 [10,42]. Adx is one
of the most thoroughly studied redox proteins to date
[43–45]. Furthermore, very recently, we have shown
that an E. coli-based whole-cell system with
CYP260A1, coexpressing the bovine ferredoxin and an
E. coli ferredoxin reductase, was able to convert D4-
C19 steroids [10]. However, the effect of the available
redox protein pool on the conversion of steroids has
not been studied. In this study, we used DOC, the D4
C-21 steroid, as a substrate which is converted into
multiple hydroxylated products so that changes in the
selectivity can easily be followed.
At first, the time dependent in vitro DOC conversion
by CYP260A1 at substrate saturation (100 lM) using
the ratio of CYP260A1 : Adx : AdR of 1 : 10 : 3 was
performed to investigate the steady-state conditions of
the conversion (Fig. 1A,B). The LC/MS measurement
of the in vitro conversion of DOC (peak S with
[M+Z]+ = 331.2) showed two main products, peak 4
(~26% with [M+H]+ of 347.2) and peak 6 (~11% with
[M+H]+ of 329.2) at retention times (tR) of 5.28 min
and 7.13 min, respectively, as well as four side-pro-
ducts corresponding to the peaks 1 (~7% with
[M+Z]+ = 363.2), 2 (~7% with [M+Z]+ = 345.2), 3
(~7% with [M+Z]+ = 347.2), and 5 (~7% with
[M+Z]+ = 347.2) at tR of 4.13, 4.41, 5.07, and
6.36 min, respectively (Fig. 1A).
We observed that the conversion was in a steady-
state condition up to 40 min (Fig. 1B). In accor-
dance with this, 20 min reaction time was used for
the subsequent in vitro conversions utilizing the same
batch of the purified CYP260A1, Adx and AdR at a
ratio of 1 : 10 : 3 for CYP260A1 : Adx : AdR
(0.5 lM : 5 lM : 1.5 lM). In order to determine the
concentration of NADPH to be used for the steady-
state condition, a saturating concentration of DOC
(100 lM) was converted using increasing concentra-
tions of NADPH (Fig. 1C), which showed values of
Km and Vmax of 354  85 lM and 1.67  0.10 min1,
respectively. The Km value does not mean the kinetic
parameter of AdR, but rather represents the concen-
tration of NADPH at which the reaction rate is half
of the maximum rate in the coupling reaction by the
redox partners and CYP260A1. Afterwards, for the sub-
sequent study of DOC conversion, 500 lM NADPH was
used. Moreover, turnover experiments of DOC (100 lM)
in the presence and absence of a NADPH regeneration
system were performed, and it was observed that the rate
is almost the same as in the case of absence of NADPH
recycling (1.7 vs 1.8 min1) (Fig. 1D). Therefore, for the
subsequent conversion of DOC by CYP260A1, different
ratios of CYP260A1 and redox partners were used in the
absence of NADPH regeneration.
Conversion of DOC by utilizing different ratios of
CYP260A1 and redox proteins
In a first set of experiments, we compared the activities
of DOC conversion for ratios of P450 : Fdx : FdR,
which have been employed in previous studies [46,47].
At first, an equimolar concentration of P450 : Adx :
AdR of 1 : 1 : 1 [46] (Fig. 2, entry A), and an increased
ratio of ferredoxin and decreased ratio of ferredoxin
reductase of 1 : 2 : 0.5 [47] (Fig. 2, entry B), as well as
a ratio allowing a higher amount of the reductase com-
pared to the P450 and the ferredoxin of 1 : 1 : 5
(Fig. 2, entry C) were used for the in vitro conversion
of DOC by CYP260A1. We observed that the conver-
sion consisting of slightly higher molar ratios of Adx
compared to CYP260A1 and AdR showed higher turn-
over (1.23 min1, i.e. nmol total products per nmol
CYP260 A1 per min) (Fig. 2, entry B) compared with
the equimolar ratio of 1 : 1 : 1 (0.90 min1) (Fig. 2,
entry A) and increased AdR ratio of 1 : 1 : 5
(0.65 min1) (Fig. 2, entry C).
In addition, we also employed the ratios of
3 : 2.5 : 1 and 8 : 3 : 1 for CYP260A1 : Adx : AdR,
displaying a higher molar ratio of P450 compared with
the redox partners for DOC conversion. These ratios
were used for the in vitro conversion of steroidal sub-
strates by mitochondrial cytochromes P450s using Adx
and AdR as redox partners [48]. We observed that the
higher ratio of CYP260A1 compared with Adx and
AdR did not increase the rate of DOC conversion,
showing a turnover of 0.60 min1 for CYP260A1 :
Adx : AdR of 3 : 2.5 : 1 (Fig. 2, entry D) and of
0.45 min1 for a ratio of 8 : 3 : 1 (Fig. 2, entry E).
In order to systematically investigate the effect of
the redox protein ratios on DOC conversion, three
experimental sets consisting of a 5- (Fig. 2, entry F–
H), 10- (Fig. 2, entry I–N) and 20-fold higher molar
ratio of Adx (Fig. 2, entry O–U) compared with
CYP260A1 at increasing ratios of AdR compared with
CYP260A1 were used (Table 1). We observed a maxi-
mum turnover rate of 2.61  0.10 min1, 1.96 
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0.10 min1 and 1.62 min1 for the ratio of CYP260A1 :
Adx : AdR of 1 : 20 : 3, 1 : 10 : 3 and 1 : 5 : 3, respec-
tively. Interestingly, it was observed that at higher ratios
of AdR than 1:3 compared with CYP260A1 a dimin-
ished turnover rate for the substrate conversion was
observed, which was also true for the ratio that has been
used for an earlier study [48] (Fig. 2, entry C). In addi-
tion, an equal or higher molar ratio of P450 compared
to Adx also showed a reduced activity (Fig. 2, entries A,
D–E). In order to reconstitute the activity of several
P450s, different ratios of the P450 and redox partners
were also employed in earlier studies. However, a higher
concentration of ferredoxin with a lower reductase ratio
[47,49–51] or a higher concentration of P450 compared
to Fdx and FdR [52] were used. Very recently, we have
observed a higher conversion of epothilone D by the
P450 EpoK when using the ratio of 1 : 20 : 3 compared
to 1 : 10 : 1 for EpoK : Fdx: reductase (either AdR,
Arh1 or FNR).
In general, as shown in Fig. 2, the highest turnover
numbers were obtained with a ratio of CYP260A1 :
Adx : AdR of 1 : 20 : 3. It has been shown that a
twofold higher concentration of adrenodoxin reductase
is required for maximal P450scc (CYP11A1) activity in
the presence of a relatively high concentration of
adrenodoxin (~10-fold) [53,54]. During the steady-state
conversion of DOC by CYP260A1, we observed that
the presence of higher amounts of Adx showed higher
activities (Fig. 2). Although the mechanism of interac-
tion of P450s with Adx-AdR is well studied for
CYP11A1 and it has been suggested that Adx can
make either productive tertiary or quaternary com-
plexes with bovine CYP11A1 [55,56] and AdR or can
shuttle electrons through the formation of Adx or Adx
dimers [57,58], the detailed mechanism of the interac-
tion of the redox partners with CYP260A1 still needs
to be elucidated. However, it can be suggested that at
higher amounts of Adx the delivery of electrons
becomes faster thus leading to an efficient DOC con-
version. In contrast, the increase in the AdR concen-
tration compared to CYP260A1 and Adx in the
in vitro reaction significantly dropped the rate of DOC
conversion (Fig. 2), which might be the result of a
decreased concentration of free Adx protein that is
required for shuttling the electrons from the AdR to
CYP260A1. In addition, the higher rate of nonspecific
NADPH oxidation by the increased reductase concen-
tration could also account for the lower conversion.
Fig. 1. Steady-state conversion of DOC by CYP260A1. (A) Chromatogram showing the conversion of DOC. The activity was
reconstituted with the heterologous redox partners Adx and AdR. The ratio of CYP260A1 : Adx : AdR was 1 : 10 : 3 containing 0.5 lM
of CYP260A1 in a 250 lL reaction mixture. The reaction was started with the addition of NADPH (500 lM) in the absence of cofactor
regeneration. The numbers indicated in the chromatogram represent the product peaks for the conversion of DOC. The peak ‘S’
represents the substrate DOC. The products corresponding to peaks 1, 4 and 6 were identified as 1a-, 14a-dihydroxy-11-DOC, 1a-
hydroxy-11-DOC and 11-deoxycorticosterone-1-ene (C1-C2-ene-11-DOC), respectively. (B) Time-dependent (0–100 min) conversion of
DOC. (C) NADPH-dependent conversion of DOC by CYP260A1. Different concentrations of NADPH (0–4 mM) were used. Vmax and Km
values were determined by plotting the substrate conversion velocities versus the corresponding NADPH concentrations and
subsequently using a hyperbolic fit (SIGMAPLOT software, Systat Software, San Jose, CA, USA). (D) Steady-state conversion of DOC in
the presence (+, solid bar) and absence (, empty bar) of cofactor (NADPH) regeneration (recycling), as explained in the ‘Materials and
methods’ section. The number on the bar represents the value of the activity. The error bar in the figures represents the standard
deviation of 3–5 independent measurements.
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Effect of redox protein ratios on the product
pattern of the DOC conversion by CYP260A1
Most interestingly, the in vitro product pattern of
DOC conversion using different ratios of P450 and the
redox proteins changed significantly when using vari-
ous ratios of the proteins. Although the same six pro-
duct peaks were observed as under the steady-state
conditions (Fig. 1B), their relationship changed consid-
erably, especially for the major product peaks 4
(tR = 5.28 min, Dm/z of +16) and 6 (tR = 7.13 min,
Dm/z of +2) as well as the minor product peak 1
(tR = 4.13 min, Dm/z of +32) (Figs 3A and S1). When
the ratio of CYP260A1 : Adx : AdR was 1 : 5 : 3,
peak 6 was the highest followed by peak 4 (Fig. 3A).
In order to study the effect of the incubation time of
the reaction, time-dependent DOC conversion in the
presence and absence of a NADPH recycling system
was performed. However, there was no change in the
product pattern (Fig. S1).
When increasing the amount of the redox proteins
relative to CYP260A1 to a ratio of
CYP260A1 : Adx : AdR of 1 : 10 : 3 or 1 : 20 : 3,
product peak 6 was gradually decreased and peak 4
(tR = 5.28 min) was increased (Fig. 3A), respectively.
The time-dependent product formation observed by
using CYP : Adx : AdR of 1 : 10 : 3 in the absence of
a NADPH recycling system did not show any differ-
ences in the product pattern compared with the
30 min to 2 h reaction time (Fig. S2).
In a subsequent experiment, when the time-depen-
dent conversion of DOC was performed in the pres-
ence of a NADPH recycling system and the highest
ratio of the redox proteins (CYP260A1 : Adx : AdR
of 1 : 20 : 3), the highest yield of the product peak 1
Fig. 2. Steady-state conversion of DOC using different ratios of CYP260A1, Adx and AdR. Different concentrations of CYP260A1 and the
redox partners Adx and AdR are shown in the Y-axis and the X-axis represents the activity (nmol total product per nmol CYP260A1 per min).
The value inside the bar represents the ratio of CYP260A1 : Adx : AdR with respect to the concentrations as shown in the Y-axis. The
entries A–E (light brown) represent the ratio of CYP260A1 : Adx : AdR of 1 : 1 : 1, 1 : 2 : 0.5, 1 : 1 : 5, 3 : 2.5 : 1, 8 : 3 : 1, respectively.
These ratios were used for the in vitro conversion in other studies. The entries F–H (blue bars), I–N (green bars) and O–U (yellow bars)
represent the redox protein pool consisting of 5-, 10- and 20-folds higher Adx concentration compared with CYP260A1 in the in vitro
conversion of DOC, in which the AdR ratio is increased as indicated. The number on the bar represents the value of the activity. The error
bar represents the standard deviation of three independent measurements. All the reactions were started adding NADPH (500 lM) and
incubated for 20 min in the absence of a NADPH recycling system. The same batches of the purified proteins were used for the reaction.
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(tR = 4.13 min) was obtained followed by the product
peaks 4 and 6 during a longer reaction time (1 h to
2 h) (Figs 4 and S3). However, analysis of the prod-
ucts obtained until 30 min showed the highest forma-
tion of peak 4 followed by peaks 1 and 6 (Fig. S3).
In addition, since surrogated redox proteins gener-
ally cause low coupling efficiency during the consump-
tion of either substrates or cofactors and thus can
generate reactive oxygen species (ROS), the in vitro
conversions were performed with the addition of radi-
cal scavengers for the ratio of 1 : 10 : 3 of
CYP260A1 : Adx : AdR. As scavenging agents ascor-
bate (neutralizing the superoxide radical, singlet oxygen
and hydroxyl radicals), catalase (decomposing hydro-
gen peroxide to water and oxygen) and superoxide dis-
mutase (SOD) (scavenger of superoxide anion) were
employed either individually or in combination. There
was no significant decrease in the catalytic rate com-
pared with the control (Fig. 5, Table S3). In addition,
to exclude the role of possible H2O2-mediated substrate
conversion in the P450 catalysis [34,41,59], the in vitro
conversion of DOC was also performed in the presence
of hydrogen peroxide. However, using H2O2 only a
negligible amount of product was formed.
An Escherichia coli-based whole-cell
bioconversion of DOC and characterization of the
products
Since we were interested to characterize the product
peaks 1, 4 and 6, which were changed according to the
availability of the redox proteins in the in vitro
Fig. 3. Comparison of the HPLC chromatogram traces obtained for the DOC conversion using different ratios of CYP260A1 and the redox
partners in vitro (Panel I). The chromatogram of DOC alone (A) represented by peak S, and in vitro product patterns in the absence of a
NADPH recycling system (B–D) using ratios of CYP260A1 : Adx : AdR of 1 : 5 : 3 (B), 1 : 10 : 3 (C) and 1 : 20 : 3 (D) are shown. The
numbers indicated in the chromatogram represent the product peaks for the conversion of DOC. The products corresponding to peaks 1, 4
and 6 were identified as 1a-, 14 a-dihydroxy-11-DOC, 1a-hydroxy-11-DOC and C1-C2-ene-11-DOC, respectively. Bar diagram showing the
comparison of the major products obtained from the in vitro conversion of DOC by CYP260A1 in the absence of a NADPH recycling system
(Panel II). The relative percentage of the product peaks 1 (black bar), 4 (gray bar) and 6 (empty bar) of the DOC conversion are shown. The
number on the bar represents the value of the relative selectivity (in %) for the products. The error bar represents the standard deviation of
3–5 independent measurements, and the values are shown in Table S1.
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reaction, CYP260A1 dependent E. coli-based whole-
cell bioconversion of DOC was performed. The in vivo
conversion of DOC using CYP260A1 and a coexpres-
sion of Adx and AdR showed an identical product
pattern as during the in vitro reaction (Figs 3 and 6).
Interestingly, the conversion of DOC after 24 h using
resting E. coli cells that have been coexpressed with
the three proteins for 24 h showed the highest yield of
peak 6 (tR = 7.13 min, Dm/z of +2) followed by peak 4
(tR = 5.28 min, Dm/z of +16) and peak 1
(tR = 7.13 min, Dm/z of +32) (Fig. 6A). In contrast, a
longer conversion period (48 h) showed a diminished
yield of peak 6 and a subsequent increase in peaks 4
and 1 (Fig. 6B). However, resting cells that were coex-
pressed with the three proteins for a longer duration
(48 h) showed the highest yield of peak 4 followed by
peaks 6 and 1 for both the conversion conditions
(24 h and 48 h) (Fig. 6C,D). It is interesting that the
product peak 1, the yield of which was almost negligi-
ble during in vitro conversion under steady conditions
(performed in the absence of NADPH recycling), has
appeared as a major product either during the in vitro
conversion for a longer time in the presence of
NADPH recycling or in the in vivo conversion of
DOC. Therefore, the appearance of peak 1 seems to
be closely related to the availability of sufficient
amounts of recycled NADPH and redox proteins.
Our optimized E. coli-based whole-cell system for
the conversion of DOC by CYP260A1 was able to give
enough yield to purify the corresponding products. The
products comprising the peaks 1, 4 and 6 were purified
and characterized by LC–MS and 1D and 2D NMR.
Products 1 (Dm/z of +32), 4 (Dm/z of +16) and 6 (Dm/z
of 2) were identified as 1a-,14a-dihydroxy-11-DOC
(1a-,14a-dihydroxylated DOC), 1a-hydroxy-11-DOC
(1a-hydroxylated DOC) and 11-deoxycorticosterone-1-
ene (21-hydroxypregna-1,4-diene-3, 20-dione or C1-C2-
ene-11-DOC), respectively. Product 1 is a novel steroid
derivative and the major product 4 is the same one as
was identified before as the main product of
CYP260A1-dependent DOC conversion [60]. Although
CYP260A1 performs mainly the C-1 hydroxylation of
DOC, the position at C-2 is prone for hydrogen
abstraction and can act as a proton donor. This might
result in a chemical modification at C-1 to generate a
product with a C-1/C-2 double bond, because of the
possible delocalization of the p system after releasing a
water molecule from the A-ring. This hypothesis is sup-
ported by the existence of the product peak 6 (C1-C2-
ene-11-DOC) along with the major peak 4. The NMR
data of product 6 also corroborated with the published
13C NMR data [61]. The detailed results of NMR spec-
troscopy or the products 1, 4 and 6 are as follows.
1a-,14a-Dihydroxy-11-deoxycorticosterone (1a-,14a-
dihydroxylated DOC) (Product 1): 1H-NMR
(500 MHz, CDCl3): d = 0.71 (s, 3H; H-18), 1.12 (m,
H-7a), 1.19 (s, 3H, H-19), 1.24 (m, H-12), 1.40 (m, H-
15a), 1.59 (m, H-15b), 1.62 (m, H-8), 1.69 (m, H-9),
1.78 (m, H-17), 1.83 (m, H-7b), 2.38 (m, H-6), 2.56
(dd, J = 16.9, 3.0, H-2a), 2.68 (m, H-16), 2.75 (dd,
Fig. 4. (A) Chromatogram showing the in vitro conversion of DOC
by CYP260A1. The reaction mixture consists of
CYP260A1 : Adx : AdR of 1 : 20 : 3 in the presence of a NADPH
recycling system. The conversion was done for 1 h. The products
corresponding to peaks 1, 4 and 6 were identified as 1a-, 14 a-
dihydroxy-11-DOC, 1a-hydroxy-11-DOC, and C1-C2-ene-11-DOC,
respectively. The peak ‘S’ represents the substrate DOC. (B) The
relative percentage of the product peaks 1 (black bar), 4 (gray bar)
and 6 (empty bar) of DOC conversion are shown. The number on
the bar represents the value of the relative selectivity (in %) for
the products. The error bar represents the standard deviation of 3–
5 independent measurements, and the values are shown in the
Table S2.
Fig. 5. The effect of radical scavengers on the catalytic rate of
DOC conversion by CYP260A1. The error bars represent the
standard deviation of 3 independent measurements, and the values
are shown in the Table S3. *SOD, superoxide dismutase.
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J = 16.9, 2.5, H-2b), 3.04 (br s, OH-21), 4.09 (s, H-1),
4.30 (d, 19.9, H-21a), 4.65 (d, J = 19.9, H-21b),
5.80 ppm (s, H-4); 13C-NMR (125 MHz, CDCl3):
d = 15.1 (C-18), 18.9 (C-19), 29.2 (C-8), 29.9 (C-12),
31.5 (C-7), 33.2 (C-6), 34.4 (C-16), 43.0 (C-10), 43.1
(C-2), 44.2 (C-9), 48.5 (C-13), 50.6 (C-17), 67.6 (C-21),
72.2 (C-1), 88.9 (C-14), 123.8 (C-4), 166.3 (C-5),
210.0 ppm (C-20).
1a-Hydroxy-11-deoxycorticosterone (1a-hydroxy-
lated DOC), (Product 4): 1H-NMR (500 MHz,
CDCl3): d = 0.69 (s, 3H; H-18), 1.08 (dddd, J = 13.0,
13.0, 11.5, 5.5, H-7a), 1.18 (s, 3H, H-19), 1.24 (m, H-
14), 1.34 (m, H-15a), 1.42 (m, H-12a), 1.43 (m, H-
11a), 1.56 (ddd, J = 11.5, 11.0, 3.5, H-8), 1.66 (dddd,
J = 11.5, 11.5, 3.5, 3.5, H-11b), 1.70 (m, H-9), 1.77 (m,
H-16a), 1.78 (m, H-15b), 1.83 (m, H-7b), 1.93 (m, H-
12b), 2.22 (m, H-16), 2.36 (m, H-6a), 2.39 (m, H-6b),
2.46 (dd, J = 9.0, 9.0, H-7b), 2.55 (dd, J = 17.0, 3.5,
H-2a), 2.75 (dd, J = 17.0, 3.0, H-2b), 3.21 (dd, J = 4.5,
4.0 OH-21), 4.08 (dd, J = 3.5, 3.0, H-1), 4.14 (dd,
J = 19.0, 4.0, H-21a) 4.20 (dd, J = 19.0, 4.5, H-21b),
5.79 ppm (dd, J = 1.0, 1.0, H-4); 13C-NMR
(125 MHz, CDCl3): d = 13.4 (C-18), 18.5 (C-19), 20.3
(C-11), 23.0 (C-16), 24.6 (C-15), 31.0 (C-7), 32.8 (C-6),
35.2 (C-8), 38.2 (C-12), 42.9 (C-2), 43.2 (C-10), 44.7
(C-9), 44.7 (C-13), 56.1 (C-14), 59.1 (C-17), 69.4 (C-
21), 72.0 (C-1), 123.5 (C-4), 166.6 (C-5), 196.4 (C-3),
210.1 ppm (C-20).
11-Deoxycorticosterone-1-ene (C1-C2-ene-11-DOC)
(Product 6): 1H-NMR (500 MHz, CDCl3): d = 0.70 (s,
3H; H-18), 1.06 (m, H-7a), 1.06 (m, H-9), 1.13 (m, H-
14), 1.21 (s, 3H, H-19), 1.26 (m, H-11a), 1.34 (m, H-
12a), 1.60 (m, H-15a), 1.62 (m, H-8), 1.67 (m, H-11b),
1.75 (m, H-15b), 1.76 (m, H-16a), 1.94 (m, H-12b),
1.95 (m, H-7b), 2.20 (m, H-16b), 2.30 (m, H-6a), 2.40
(m, H-6b), 2.44 (m, H-17), 4.16 (d, J = 6.4 Hz, 2H, H-
21), 6.06 (t, J = 1.5, H-4), 6.23 (dd, J = 10.1, 1.8, H-
2), 7.02 ppm (d, J = 10.1, H-1);13C-NMR (125 MHz,
CDCl3): d = 13.6 (C-18), 18.7 (C-19), 22.7 (C-11), 22.9
(C-16), 24.7 (C-15), 32.7 (C-6), 33.5 (C-7), 35.5 (C-8),
38.2 (C-12), 43.4 (C-10), 44.8 (C-13), 52.1 (C-9), 55.6
(C-14), 58.9 (C-17), 69.4 (C-21), 124.0 (C-4), 127.2 (C-
Fig. 6. The Escherichia coli-based whole-cell conversion of DOC by CYP260A1. The product pattern of DOC conversion obtained after 24 h
(A) and 48 h (B) by coexpressing CYP260A1, Adx and AdR for 24 h in the E. coli cells was compared with the conversion of the substrate
for 24 h (C) and 48 h (D) using 48 h coexpressed cells (Panel I). The numbers indicated in the chromatogram represent the percentage of
the product peaks for the conversion of DOC. The products corresponding to peaks 1, 4 and 6 were identified as 1a-, 14a-dihydroxy-11-
DOC, 1a-hydroxy-11-DOC, and C1-C2-ene-11-DOC, respectively. The peak ‘S’ represents the substrate DOC. The relative percentage of the
product peaks 1 (black bar), 4 (gray bar) and 6 (empty bar) of DOC conversion are shown (Panel II). The number on the bar represents the
value of the relative percentage selectivity for the products. The error bar represents the standard deviation of 3–5 independent
measurements, and the values are shown in the Table S4.
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2), 155.5 (C-1), 168.8 (C-5), 186.4 (C-3), 210.2 ppm
(C-20).
In order to study, whether the product peaks 1
(1a-,14a-dihydroxy-11-DOC) and 6 (C1-C2-ene-11-
DOC) were derived from the major product peak 4
(1a-hydroxy-11-DOC), we investigated the conversion
of purified 1a-hydroxy-11-DOC either in the presence
or in the absence of a NADPH recycling system with
a protein ratio of 1 : 10 : 3 for CYP260A1 : Adx :
AdR. We observed the formation of product peaks 1
and 6 during the conversion of 1a-hydroxy-11-DOC,
thus supporting a processive reaction type. Interest-
ingly, the presence of a NADPH recycling system
showed a higher amount of product peak 1 followed
by peak 6 compared with the conversion done for
30 min in the absence of the recycling system (Fig. 7),
suggesting that the availability of higher amounts of
redox proteins in vitro promoted the further conver-
sion of the primary product(s) into subsequent sec-
ondary product(s). Although we showed further
conversion of peak 6 (C1-C2-ene-11-DOC) into peak 4
(1a-hydroxy-11-DOC) under in vivo conditions (Fig. 6)
or upon complete consumption of DOC in the
in vitro reaction (Figs 4 and S3), it seemed controver-
sial that peak 6 was also observed during the conver-
sion of peak 4 (1a-hydroxy-11-DOC) as a substrate
(Fig. 7). However, because of the possible delocaliza-
tion of the p-system during the release of a water
molecule from the A-ring of 1a-hydroxy-11-DOC, the
C-1 could readily generate isomers with a C-1 and C-
2 double bond to give peak 6 (C1-C2-ene-11-DOC).
The mechanism for the predominance of peak 4
either by a spontaneous conversion of C1-C2-ene-11-
DOC or CYP260A1 mediated hydration reaction is
not elucidated.
Since we observed the further conversion of 1a-
hydroxy-11-DOC to 1a-,14a-dihydroxy-11-DOC and
C1-C2-ene-11-DOC by CYP260A1, we were interested
to study the binding affinity of DOC and its major
conversion product 1a-hydroxy-11-DOC for CYP2
60A1. Interestingly, 1a-hydroxy-11-DOC showed an
about ~2-fold tighter binding compared with DOC
displaying Kd values of 0.52  0.14 lM and
0.27  0.01 lM for DOC and 1a-hydroxy-11-DOC,
respectively (Fig. 8). This observation suggests that the
binding of the surrogate redox partners might have
induced an open confirmation of CYP260A1 so that
1a-hydroxy-11-DOC can be released from CYP260A1
and enter again into the active site of CYP260A1 in a
different orientation. Indeed, our very recent study on
the docking of DOC into the crystal structure of
CYP260A1 also showed two different orientations of
DOC in its active site [59], in which DOC was oriented
either having ring-A or ring-D close to the heme center
(Fig. S4). We hypothesized that the major product 1a-
hydroxy-11-DOC might have re-entered into the active
site of CYP260A1 in a flipped orientation compared
with the position allowing the most feasible 1a-hydro-
xylation to reveal an additional hydroxylation site at
position 14 producing 1a-,14a-dihydroxy-11-DOC.
Most importantly, the observed open conformation of
P450cam complexed with its redox partner putidare-
doxin (Pdx) in the crystal structure of oxidized and
reduced form [62] also suggested that the redox protein
induced an open conformation.
In conclusion, the conversion of DOC by
CYP260A1 showed three main product peaks (1, 4
and 6) and the product patterns varied in
Fig. 7. Conversion of 1a-hydroxy-11-DOC by CYP260A1.
Chromatograms of DOC (A) and the purified 1a-hydroxy-11-DOC
(B); the chromatogram showing the conversion of 1a-hydroxy-11-
DOC, peak 4, (B) into the product peaks 1 and 6 in the absence (C)
and presence (D) of a NADPH recycling system. The activity was
reconstituted with the heterologous redox partners Adx and AdR.
The ratio of CYP260A1 : Adx : AdR was 1 : 10 : 3. The reactions
in the absence (C) and presence (D) of a NADPH recycling system
were done for 30 min and 1 h, respectively. The products
corresponding to peaks 1, 4 and 6 were identified as 1a-, 14a-
dihydroxylated-11-DOC, 1a-hydroxy-11-DOC, and 11-deoxycorticost
erone-1-ene (C1-C2-ene-11-DOC), respectively. The asterisk ‘*’
represent the unidentified product.
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dependence on the employed redox protein ratios. A
low concentration of the redox proteins (CYP260A1
: Adx : AdR of 1 : 5 : 3) showed the formation of
peak 6 (C1-C2-ene-11-DOC) as the major one fol-
lowed by peak 4 (P6 > P4). When using higher
redox protein ratios (1 : 10 : 3 and 1 : 20 : 3 for
CYP260A1 : Adx : AdR), the in vitro conversion
showed the formation of peak 4 (1a-hydroxy-11-
DOC) as the major one. However, the product peak
6 was higher for the ratio 1 : 10 : 3 compared with
1 : 20 : 3 showing product patterns of P4 > P6 > P1
and P4 > P1 > P6, respectively (Fig. 3). In addition,
the presence of higher amounts of redox proteins
(CYP260A1 : Adx : AdR of 1 : 20 : 3) and the avail-
ability of a cofactor (NADPH) recycling system
showed the highest yield of the product peak 1 (1a-,
Fig. 8. Deoxycorticosterone (Panel I) and
1a-hydroxy-11-DOC (Panel II) binding to
CYP260A1. The absorbance spectra of
oxidized CYP260A1 (1.12 lM, panel I, and
0.90 lM, panel II) and increasing
concentrations of the substrates are
shown in the main image (A), in which the
Soret band maximum is gradually shifting
from 417 nm (pointing down) to 393 nm
(pointing up) during the addition of
increasing concentrations of substrates.
The inset B shows the overlaid difference
spectra produced by subtraction of the
spectrum for ligand-free CYP260A1 from
the successive spectra for substrate-
bound species accumulated during the
titration between 0 and 2 lM of DOC
(Panel I) and 0 and 2.5 lM of 1a-hydroxy-
11-DOC (Panel II). The plots of absorbance
change vs. concentration of the substrate
from the titration were plotted to a tight
binding quadratic equation as described in
‘Materials and Methods’ and the
CYP260A1 dissociation constants (Kd
value) were identified (inset C).
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14a-dihydroxy-11-DOC) followed by the peaks 4 and
peak 6 (Fig. 4). We also showed the conversion of
the purified product of peak 4 into peaks 1 and 6,
suggesting further conversion of the preformed pro-
duct(s). Taken together, this study showed that the
amount of redox partners can be used to tune the
P450-dependent reaction either producing one main
product (1a-hydroxy-11-DOC) or getting a more
diverse product spectrum (e.g. 1a-, 14a-dihydroxy-11-
DOC or C1-C2-ene-11-DOC) as illustrated in
Scheme 1.
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Supporting information
Additional Supporting Information may be found
online in the supporting information tab for this arti-
cle:
Table S1. Rate of formation of product peaks 1, 4 and
6 in the in vitro conversion of DOC using different
redox protein ratios of Adx and AdR by CYP260A1
in the absence of a NADPH recycling system.
Table S2. Rate of formation of product peaks 1, 4 and
6 in the in vitro conversion of DOC using
CYP260A1 : Adx : AdR of 1 : 20 : 3 in the presence
of a NADPH recycling system.
Table S3. Rate of in vitro conversion of DOC by
CYP260A1 in the presence of radical scavengers.
Table S4. Rate of formation of product peaks 1, 4 and
6 in the E. coli-based whole-cell conversion of DOC
by CYP260A1.
Fig. S1. Chromatogram showing the conversion of
DOC in the absence (A) and presence (B) of a
NADPH recycling system using the ratio of
CYP260A1 : Adx : AdR of 1 : 5 : 3.
Fig. S2. Chromatogram showing the conversion of
DOC in the absence of a NADPH recycling system for
30 min (B), 1 hr (C) and 2 hr (D) using the ratio of
1 : 10 : 3 for CYP260A1 : Adx : AdR.
Fig. S3. Chromatogram showing the conversion of
DOC in the presence of a NADPH recycling system
for 30 min (A), 1 hr (B), 1 hr 30 min (C) and 2 hr (D)
using the ratio of 1 : 10 : 3 for
CYP260A1 : Adx : AdR.
Fig. S4. Docking conformations of DOC into the crys-
tal structure of CYP260A1. The docking poses II (A),
III (B) and IV (C) are shown as observed in our earlier
studies [59].
1140 FEBS Letters 591 (2017) 1126–1140 ª 2017 Federation of European Biochemical Societies
P450 catalysis depends on redox protein ratios Y. Khatri et al.
